PLAY PODCASTS
The Long Run with Luke Timmerman

The Long Run with Luke Timmerman

"The Long Run" Antarctic explorer Ernest Shackle…

Timmerman Report · The Long Run with Luke Timmerman

212 episodesEN

Show overview

The Long Run with Luke Timmerman has been publishing since 2017, and across the 9 years since has built a catalogue of 212 episodes. That works out to roughly 230 hours of audio in total. Releases follow a fortnightly cadence.

Episodes typically run an hour to ninety minutes — most land between 1h and 1h 10m — and the run-time is fairly consistent across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.

The show is actively publishing — the most recent episode landed 3 days ago, with 23 episodes already out so far this year.

Episodes
212
Running
2017–2026 · 9y
Median length
1h 5m
Cadence
Fortnightly

From the publisher

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Latest Episodes

View all 212 episodes

Ep214: Shana Kelley on a Wearable Continuous Immune Monitor

Nov 16, 202647 min

Ep213: Daphne Koller on The Moment in AI Drug Discovery

Nov 3, 20261h 4m

Ep212: Tim Shannon on Creating Targeted Protein Degraders as Medicines

Oct 23, 20261h 14m

Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience

Oct 7, 20261h 6m

Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders

Sep 23, 20261h 3m

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

Sep 9, 20261h 36m

Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus

Aug 25, 20261h 7m

Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases

Aug 11, 20261h 17m

Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases

Jul 28, 20261h 7m

Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

Jul 14, 20261h 8m

Ep204: Troy Wilson on Precision Cancer Drugs and Combos

Jun 30, 20261h 7m

Ep203: Sri Kosuri on Small Molecule Correctors of Disease

Jun 16, 20261h 11m

Ep202: Becky Pferdehirt on Reimagining Science for the AI Era

Jun 2, 20261h 8m

Ep201: Jeremy Levin on Biotech in the Balance

May 19, 20261h 8m

Ep200: Richard Pops on Orexin Drugs For Sleep Disorders & More

May 5, 20261h 13m

Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era

Apr 21, 20261h 10m

Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery

Abbas Kazimi, CEO of Boston-based Nimbus Therapeutics, on computation and culture for drug discovery.

Apr 7, 20261h 16m

Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature

Viswa Colluru, founder and CEO of Boulder, Colo.-based Enveda, on drug discovery with a chemistry platform inspired by natural products.

Mar 31, 20261h 16m

Ep196: Otello Stampacchia on Europe's Biotech Crisis

Otello Stampacchia, founder and managing director of Omega Funds, on attempting to reform Europe's biotech investment climate.

Mar 17, 20261h 3m

Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.

Mar 3, 20261h 5m
All rights reserved